INS and type 2 diabetes mellitus: As the main impairment in insulin signaling in T2D is thought to occur at the level of insulin receptor substrates rather than downstream signaling components (Rui et al., 2002; Hançer et al., 2014), compensatory increases in downstream proteins are possible, although several cellular mechanisms likely contribute (Accili et al., 2025).